GRO Biosciences
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
750 Main St, Cambridge, Massachusetts, 0...Phone Number
(617) 903-8359Website
www.grobio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About GRO Biosciences
GRO Biosciences is leveraging groundbreaking science to expand the amino acid alphabet and deliver on the promise of protein therapeutics. GRO Biosciences was founded in 2016 and based in Cambridge, Massachusetts.Explore more
GRO Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GRO Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once GRO Biosciences has new funding data
Earning: See what the market has to say on GRO Biosciences recently announced quarterly report
Check out if GRO Biosciences is spiking on competitors!
GRO Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when GRO Biosciences launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if GRO Biosciences had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at GRO Biosciences
Check if GRO Biosciences has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to GRO Biosciences
Compare insights from companies similar to GRO Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
GRO Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
GRO Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about GRO Biosciences.
GRO Biosciences financials insights
Gather financial insights about GRO Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Angel/Seed
$2.1M
2021
Series A
$25M
2024
Series B
$60.3M
GRO Biosciences Tech Stack
A closer look at the technologies used by GRO Biosciences
Most Recent Scoops
Open Position
Funding
Funding
New Hire
Executive Move
New Hire
Executive Move
Funding
GRO Biosciences News & Media
GRO Biosciences Closes $60M Series B
BOSTON, MA, GRO Biosciences, a biotechnology company, announced the closing of an oversubscribed $60.3 million Series B financing.GRO gathers $60M series B to take gout therapy into clinic - Fierce Biotech
The protein therapeutics-focused biotech will use the money to push its lead gout treatment ProGly-Uricase into clinical trials.GRO Biosciences Closes $60M Series B Financing Co-Led by Atlas Venture and Access Biotechnology
BOSTON--(BUSINESS WIRE)--GRO Biosciences Inc. (“GRObio”), a biotechnology company leveraging synthetic biology to expand the amino acid alphabet and deliver on the promise of protein therapeutics, today announced the closing of an oversubscribed $60.3 million Series B financing. Proceeds from the financing will be used to advance the Company’s lead program into the clinic for the treatment of refractory gout, to broaden the GRObio pipeline, and to expand its genomically recoded organism (GRO) pGRO Biosciences Expands Executive Team with Appointment of Biopharma Veteran Tracey Lodie, PhD as Chief Development Officer
BOSTON--(BUSINESS WIRE)--GRO Biosciences Inc. (“GRObio”), an emerging biotechnology company leveraging synthetic biology to expand the amino acid alphabet and deliver on the promise of protein therapeutics, today announced the expansion of its leadership with the hire of Tracey Lodie, PhD as Chief Development Officer. Dr. Lodie has more than 20 years of experience in the biopharmaceutical industry focused on the discovery and development of novel biologics and cell therapies in the areas of aut
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding GRO Biosciences
Sign Up For FreeTo access detailed company insights
GRO Biosciences is leveraging groundbreaking science to expand the amino acid alphabet and deliver on the promise of protein therapeutics. GRO Biosciences was founded in 2016 and based in Cambridge, Massachusetts.... Read More
